Authors

Andrew Radtke, MD
Recent : Going “retro”: A perspective on robotic retroperitoneal renal surgery
Caroline Seymour
Recent : Pembrolizumab plus cabozantinib highly active in metastatic kidney cancer
Brian Helfand, MD, PhD
Recent : Follow-Up After Negative Bone/CT in Prostate Cancer With Molecular Recurrence 
Kathleen M. Olson, MD
Recent : Urologic implications of Lynch syndrome
Mark D. Tyson, MD, MPH
Recent : Urologic implications of Lynch syndrome
Matthew Fowler
Recent : Pembrolizumab plus lenvatinib shows promise metastatic kidney cancer
Courtney Marabella
Recent : Cabozantinib significantly delays progression in papillary RCC
Darlene Dobkowski, MA
Recent : QoL boost linked to higher lenvatinib dose in kidney cancer
LAURENCE A. LEVINE, MD
Recent : Making Sense of the Reintervention Rate for BPH
Dylann Cohn-Emery
Recent : Latest tivozanib data shared as FDA weighs kidney cancer approval